European Archives - Page 675 of 1111 - European Medical Journal

Pregnancy Duration Changes Newborn DNA

Pregnancy Duration Changes Newborn DNA

DURATION of pregnancy has been linked with chemical DNA changes in newborns and may direct future understandings in the care of premature infants…

An Interview with Prof Jonathan Sackier at the International Colorectal Disease Symposium 2020

Spencer Gore, CEO of EMG-Health, speaks to Professor Jonathan Sackier at the International Colorectal Disease Symposium in Israel about EMG-Health…

Expert Update for Doctors on COVID-19: A Summary of the Event

A point of concern also highlighted by Prof Maria Zambon is poor preparedness for such an outbreak in low-resource settings. Certain countries in Africa…

London

EMJ Nephrology 8 [Suppl 1] 2020

Therapeutic plasma exchange (TPE) is a commonly administered technique for the treatment of a variety of conditions characterised by elevated levels of pathophysiological plasma components, including Guillain–Barré syndrome, acute myasthenia gravis, and cryoglobulinaemia.

London

A Change for Better Exchange – From Membrane Therapeutic Plasma Exchange to Centrifugal Therapeutic Plasma Exchange

Plasmapheresis is an extracorporeal procedure in which plasma is separated from the cellular components of the blood and then either donated or discarded…

Balkan Endemic Nephropathy Linked to Contaminated Groundwater - Image

Balkan Endemic Nephropathy Linked to Contaminated Drinking Water

A UNIQUE type of endemic kidney disease, originating in farming villages located along the Danube River in Balkan countries, is now thought…

Benefits of Eliminating Prehydration Prior to CT Scans for Patients with Chronic Kidney Disease - Image

Benefits of Eliminating Prehydration Prior to CT Scans for Patients with Chronic Kidney Disease

THE SAFETY and cost-effectiveness of not giving prehydration to patients with chronic kidney disease (CKD) prior to a CT scan has been preliminary…

EMJ Dermatology 8 [Suppl 2] 2020

The 24th World Congress of Dermatology (WCD) and 28th European Academy of Dermatology and Venereology (EADV) Congress both delivered a host of symposia…

Biologics in Moderate-to-Severe Psoriasis: Discover the Road to Long-term Control

Advances in the treatment of moderate-to-severe psoriasis have accelerated considerably in the last 30 years. Prof Piaserico provided an overview of the…

Tildrakizumab in Patients with Moderate-to-Severe Psoriasis: Post-Hoc Analyses on Efficacy, Time to Relapse, Long-Term Safety in Elderly Population and Predictability From The reSURFACE 1 and reSURFACE 2 Phase III Clinical Trials

Psoriasis is a chronic, relapsing inflammatory skin disease, characterised in most cases by sharply demarcated, erythematous, pruritic plaques covered…